IP Library Granted Patent US 9,549,998
Granted Patent B2
US 9,549,998 · App. 12/665,086 · Granted Jan 24, 2017

Stabilized gold nanoparticle and contrast agent

Inventors: Vijaya Kattumuri (Surrey, CA); Kattesh V. Katti (Columbia, MO); Evan Boote (Columbia, MI); Raghuraman Kannan (Columbia, MO); Stan Casteel (Auxvasse, MO); Robert Churchill (Columbia, MO)
Assignee: The Curators of the University of Missouri
A61K49/0428A61B6/508B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,549,998
App. No.
12/665,086
Granted
Jan 24, 2017
Kind
B2
Abstract

A kit for providing a contrast enhancer in a mammal for contrasting during imaging of the mammal comprises functionalized gold nanoparticles configured to be directed to one or more of a target organ, tissue and lesion of the mammal.

Claims (11)

1. A kit for providing a contrast enhancer in a mammal for contrasting during imaging of the mammal, the kit consisting of:

gold nanoparticles functionalized with a biomolecule for engagement with a target portion of the mammal, wherein the gold nanoparticles are directly coated with bisphosphonate and gum arabic; and

an aqueous solution of the gum arabic.

2. A kit as defined by claim 1 wherein the coated gold nanoparticles are functionalized with a bombesin molecule, and wherein the target portion of the mammal comprises a lesion.

3. A kit as defined by claim 1 wherein the coated gold nanoparticles are provided in a dosage sufficient to cause engagement between a target portion of the mammal in a ratio of at least 1 mg gold nanoparticles/gm of target portion of the mammal.

4. A kit as defined by claim 1 wherein the coated gold nanoparticles are configured to allow a period of at least about 24 hours after injection into the mammal before using an imaging apparatus to perform imaging on the mammal.

5. A kit as defined by claim 1 wherein the coated gold nanoparticles have a diameter of less than about 20 nm and the target portion of the mammal is the lungs.

6. A kit as defined by claim 1 wherein the coated gold nanoparticles have a diameter of greater than about 20 nm and the target portion of the mammal is one or more of the liver and the spleen.

7. A kit as defined by claim 1 wherein the coated gold nanoparticles are provided in a dosage of between about 2 and about 45 mg per kilogram body weight of the mammal.

8. A kit as defined by claim 1 wherein the coated gold nanoparticles are provided in a dosage of between about 1 and about 5 mg per kilogram body weight of the mammal.

9. A kit as defined by claim 1 wherein the target portion of the mammal comprises one or more of an organ, tissue or a lesion.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2010
From: KATTUMURI, VIJAYA; KATTI, KATTESH V.; BOOTE, EVAN; KANNAN, RAGHURAMAN; CASTEEL, STAN; CHURCHILL, ROBERT
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 024601/0058 →
CONFIRMATORY LICENSE Recorded Mar 26, 2010
From: UNIVERSITY OF MISSOURI COLUMBIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024143/0825 →
Continuity (2)
Provisional Application 60937475 · Jun 28, 2007
Related Publication 20100266508A1 · Oct 21, 2010